These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 23625408)

  • 1. Phosphopeptide microarrays for comparative proteomic profiling of cellular lysates.
    Gao L; Sun H; Uttamchandani M; Yao SQ
    Methods Mol Biol; 2013; 1002():233-51. PubMed ID: 23625408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative proteomic profiling of mammalian cell lysates using phosphopeptide microarrays.
    Gao L; Uttamchandani M; Yao SQ
    Chem Commun (Camb); 2012 Feb; 48(16):2240-2. PubMed ID: 22252530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel breast cancer biomarkers identified by integrative proteomic and gene expression mapping.
    Ou K; Yu K; Kesuma D; Hooi M; Huang N; Chen W; Lee SY; Goh XP; Tan LK; Liu J; Soon SY; Bin Abdul Rashid S; Putti TC; Jikuya H; Ichikawa T; Nishimura O; Salto-Tellez M; Tan P
    J Proteome Res; 2008 Apr; 7(4):1518-28. PubMed ID: 18318472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Proteomics and breast cancer].
    Mathelin C; Tomasetto C; Cromer A; Rio MC
    Gynecol Obstet Fertil; 2006 Dec; 34(12):1161-9. PubMed ID: 17123853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics of breast carcinoma.
    Somiari RI; Somiari S; Russell S; Shriver CD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Feb; 815(1-2):215-25. PubMed ID: 15652811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating titania enrichment, iTRAQ labeling, and Orbitrap CID-HCD for global identification and quantitative analysis of phosphopeptides.
    Wu J; Warren P; Shakey Q; Sousa E; Hill A; Ryan TE; He T
    Proteomics; 2010 Jun; 10(11):2224-34. PubMed ID: 20340162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteome profile of the MCF7 cancer cell line: a mass spectrometric evaluation.
    Sarvaiya HA; Yoon JH; Lazar IM
    Rapid Commun Mass Spectrom; 2006; 20(20):3039-55. PubMed ID: 16986208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical proteomics in breast cancer: a review.
    Gast MC; Schellens JH; Beijnen JH
    Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reverse-phase protein microarrays.
    Pierobon M; Vanmeter AJ; Moroni N; Galdi F; Petricoin EF
    Methods Mol Biol; 2012; 823():215-35. PubMed ID: 22081348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiling protein interaction networks with functional protein microarrays.
    Mattoon DR; Schweitzer B
    Methods Mol Biol; 2009; 563():63-74. PubMed ID: 19597780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers of breast cancer apoptosis induced by chemotherapy and TRAIL.
    Leong S; McKay MJ; Christopherson RI; Baxter RC
    J Proteome Res; 2012 Feb; 11(2):1240-50. PubMed ID: 22133146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isotope-labeling and affinity enrichment of phosphopeptides for proteomic analysis using liquid chromatography-tandem mass spectrometry.
    Kota U; Chien KY; Goshe MB
    Methods Mol Biol; 2009; 564():303-21. PubMed ID: 19544030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular make-up of a tumour: proteomics in cancer research.
    Kolch W; Mischak H; Pitt AR
    Clin Sci (Lond); 2005 May; 108(5):369-83. PubMed ID: 15831087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reverse phase protein microarrays for monitoring biological responses.
    Espina V; Wulfkuhle JD; Calvert VS; Petricoin EF; Liotta LA
    Methods Mol Biol; 2007; 383():321-36. PubMed ID: 18217695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of phosphoprotein signatures of archived prostate cancer tissue specimens via proteomic analysis.
    Chen L; Fang B; Giorgianni F; Gingrich JR; Beranova-Giorgianni S
    Electrophoresis; 2011 Aug; 32(15):1984-91. PubMed ID: 21739434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein microarrays for cancer diagnostics and therapy.
    Lin JC
    Med Princ Pract; 2010; 19(4):247-54. PubMed ID: 20516699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of pathways associated with invasive behavior by ovarian cancer cells using multidimensional protein identification technology (MudPIT).
    Sodek KL; Evangelou AI; Ignatchenko A; Agochiya M; Brown TJ; Ringuette MJ; Jurisica I; Kislinger T
    Mol Biosyst; 2008 Jul; 4(7):762-73. PubMed ID: 18563251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue sample preparation for biomarker discovery.
    Suehara Y; Kubota D; Saito T
    Methods Mol Biol; 2013; 1002():13-23. PubMed ID: 23625391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression signatures and biomarkers of noninvasive and invasive breast cancer cells: comprehensive profiles by representational difference analysis, microarrays and proteomics.
    Nagaraja GM; Othman M; Fox BP; Alsaber R; Pellegrino CM; Zeng Y; Khanna R; Tamburini P; Swaroop A; Kandpal RP
    Oncogene; 2006 Apr; 25(16):2328-38. PubMed ID: 16314837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global profiling of phosphopeptides by titania affinity enrichment.
    Wu J; Shakey Q; Liu W; Schuller A; Follettie MT
    J Proteome Res; 2007 Dec; 6(12):4684-9. PubMed ID: 17929885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.